Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Eye

• Publication date

  2010-04-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.2010.61PMID 20431610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

  2009cited by this paper
• BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II

  2009cited by this paper
• Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.

  2009cited by this paper
• Bevacizumab in the treatment of idiopathic macular telangiectasia

  2008cited by this paper
• Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

  2008cited by this paper
• Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia

  2008cited by this paper
• LONG-TERM EFFECT OF INTRAVITREAL TRIAMCINOLONE IN THE NONPROLIFERATIVE STAGE OF TYPE II IDIOPATHIC PARAFOVEAL TELANGIECTASIA

  2008cited by this paper
• Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

  2007cited by this paper
• Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis

  2007cited by this paper
• Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.

  2007cited by this paper
• Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.

  2006cited by this paper
• Idiopathic Macular Telangiectasia

  2006cited by this paper
• Treatment of CNVM secondary to idiopathic juxtafoveal retinal telangiectasis by transpupillary thermotherapy.

  2005cited by this paper
• Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.

  2004cited by this paper
• Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.

  2004cited by this paper
• Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

  2004cited by this paper
• Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.

  2003cited by this paper
• Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.

  1997cited by this paper
• Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

  1997cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis.

  1982cited by this paper
• Parafoveal retinal telangiectasis: Light and electron microscopy studies

  1980cited by this paper
• Retinal telangiectasis in adults: fluorescein angiographic findings and treatment by argon laser.

  1978cited by this paper

• Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1

  2026cites this paper
• Navigated laser treatment with preliminary anti-VEGF therapy in macular telangiectasia type 1

  2025cites this paper
• Idiopathic macular telangiectasia type 1: Clinical, multimodal imaging features and response to treatment.

  2025cites this paper
• Maladie de Coats et télangiectasies rétiniennes

  2024cites this paper
• Efficacy of Laser Photocoagulation for Type 1 Idiopathic Macular Telangiectasia: A Retrospective Study

  2021cites this paper
• Atypical bilateral presentation in idiopathic macular telangiectasia type 1.

  2021cites this paper
• Idiopathic Macular Telangiectasia

  2020cites this paper
• Focal láser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept.

  2020cites this paper
• Láser focal para telangectasia macular idiopática tipo 1 refractario a ozurdex, ranibizumab y aflibercept

  2020cites this paper
• Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation

  2020cites this paper
• Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept

  2020cites this paper
• Atypical bilateral presentation in idiopathic macular telangiectasia type 1.

  2020cites this paper
• Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia

  2019cites this paper
• The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases

  2019cites this paper
• INSIGHTS INTO PERIFOVEAL EXUDATIVE VASCULAR ANOMALOUS COMPLEX.

  2018cites this paper
• Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia.

  2018cites this paper
• Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature

  2017cites this paper
• Widening use of dexamethasone implant for the treatment of macular edema

  2017cites this paper
• widening use of dexamethasone implant for the treatment of macular edema

  2017cites this paper
• Exudative retinal detachment.

  2017cites this paper
• CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS

  2017cites this paper
• Intravitreal Ranibizumab Treatment for Non-Proliferative Idiopathic Macular Telangiectasia

  2017cites this paper
• Diagnostic and therapeutic challenges.

  2017cites this paper
• EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE

  2017cites this paper
• Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

  2017cites this paper
• Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia.

  2016cites this paper
• Dexamethasone Implant for the Treatment of Type 1 Idiopathic Macular Telangiectasia

  2016cites this paper
• Therapeutic Monoclonal Antibodies and Fragments: Bevacizumab.

  2016cites this paper
• SHORT-TERM FLUCTUATION OF MACULAR EDEMA IN A PATIENT DIAGNOSED EARLY WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1: FOLLOW-UP WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.

  2016cites this paper
• Combination Therapy with Photodynamic Therapy and Intravitreal Bevacizumab in Idiopathic Macular Telangiectasia Type I

  2016cites this paper
• Maladie de Coats et télangiectasies

  2016cites this paper
• PEARLS AND PITFALLS IN DIAGNOSIS AND MANAGEMENT OF COATS DISEASE

  2015cites this paper
• Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab

  2014cites this paper
• Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)

  2014cites this paper
• [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].

  2013cites this paper
• Diagnostic and therapeutic challenges.

  2013cites this paper
• Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.

  2013cites this paper
• Macular telangiectasia type 2.

  2013cites this paper
• Image Quality Improvement in Adaptive Optics Scanning Laser Ophthalmoscopy Assisted Capillary Visualization Using B-spline-based Elastic Image Registration

  2013cites this paper
• EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2

  2012cites this paper
• Intravitreal Injection of Bevacizumab to Treat a Macular Edema Caused by Leber's Miliary Aneurysm

  2012cites this paper
• RETINAL STRUCTURAL ALTERATIONS AND MACULAR SENSITIVITY IN IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1

  2012cites this paper
• Response to ‘Bevacizumab and type 1 idiopathic macular telangiectasia’

  2011cites this paper
• Presumed entecavir-induced ocular toxicity

  2011cites this paper
• Bevacizumab and type 1 idiopathic macular telangiectasia

  2011cites this paper